Skip to main content

Reinsurance

Best affirms Africa Re

AM Best Co. has affirmed the financial strength rating of A- (Excellent) and the issuer credit rating of "a-" of African Reinsurance Corporation (Nigeria). The outlook for both ratings has been revised to stable from negative.

Best affirms Axis, waits for Charman successor plan

AM Best has affirmed the financial strength rating (FSR) of A (Excellent) and the issuer credit ratings (ICR) of "A" of Bermudian (re)insurer Axis Specialty Limited (Axis) and its operating affiliates. Concurrently, the agency has affirmed the ICR of …

Lloyd's climate change debate falls short says Ascot

A leading Lloyd's underwriter has criticised the market's opening debate on climate change for providing "little true weight" and predictable "rhetoric". Matthew Washington, aggregate manager at Ascot Underwriting, said of the Lloyd’s 360 Debate on…

Tower Group enters novation agreements with PXRE

Tower Group has announced that it has concluded, through commutation agreements, PXRE Reinsurance Company's participation under various reinsurance agreements with Tower Insurance Company of New York covering the 2001, 2002 and a portion of the 2003…

Ernst & Young signs up for Benfield’s ReMetrica

Benfield has announced that Ernst & Young has signed an agreement to license its ReMetrica Dynamic Financial Analysis (DFA) modelling tool to undertake a range of economic capital modelling work for its insurance and reinsurance clients around the world.

Swiss Re completes FPK sale

Swiss Re has completed the sale of its wholly owned subsidiary Fox-Pitt, Kelton (FPK) to an investor group led by J.C. Flowers and by FPK management. Swiss Re will hold a minority interest in the new company.

Validus increases leverage

Validus Holdings has announced that it has raised $150m through a private sale of junior subordinated deferrable interest debentures as part of a pooled transaction.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here